MG
XBI icon

Marex Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Marex Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$829K – 1021
2025
Q2 		$829K Buy
+10,000
New +$798K 0.01% 311

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Marex Group's XBI Position: Q1 2026 in Review

Marex Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 3,588 shares worth $458K. The stake represents ﹤0.01% of the portfolio and ranks #649 among its holdings. This is a return to the name: Marex Group previously reported a position in XBI as recently as Q3 2025.

Marex Group first reported a position in XBI in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.36M in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Marex Group held 3,588 shares of State Street SPDR S&P Biotech ETF worth $458K as of Q1 2026.
  • State Street SPDR S&P Biotech ETF was a new Marex Group position in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #649 holding.
  • Marex Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 8 quarters since.
  • Marex Group's State Street SPDR S&P Biotech ETF position peaked at $2.36M in Q3 2024.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.